Current treatment of vascular Behcet′s disease
10.3760/cma.j.cn115396-20210407-00144
- VernacularTitle:血管型白塞病的治疗现状
- Author:
Runze SONG
1
;
Si CAI
;
Ruisheng QU
;
Yu WANG
;
Dong ZHOU
;
Anping ZHANG
Author Information
1. 兰州大学第二医院血管外科 730030
- Keywords:
Behcet′s disease;
Vascular type;
Thrombosis;
Interleukins
- From:
International Journal of Surgery
2021;48(9):643-648
- CountryChina
- Language:Chinese
-
Abstract:
Behcet′s disease is a chronic, multisystemic, inflammatory disease characterized by recurrent episodes of mucous membranes, eyes, musculoskeletal, blood vessels, central nervous system, and gastrointestinal tract.The treatment of Behcet′s disease varies according to the degree of organ involvement, gender and age of the patient, and there is no standard treatment. Behcet′s disease can be divided into vascular type, gastrointestinal type and neural type. Vascular type often leads to high mortality and disability rate.Glucocorticoids, azathioprine and cyclophosphamide are still recommended as first-line treatments for vascular Behcet′s disease.However, with the use of tumor necrosis factor inhibitors, they are an acceptable option for the treatment of refractory vascular Bezier′s disease.This article reviews the current treatment of vascular Behcet′s disease.
